BERLIN — The European Union says vaccine maker AstraZeneca has agreed to supply 9 million additional doses to the 27-nation bloc during the first quarter.
The new target of 40 million doses by the end of March is still only half what the company had originally aimed for, triggering a spat between AstraZeneca and the EU last week.
European Commission President Ursula von der Leyen said late Sunday that the British-Swedish pharmaceutical maker will also begin deliveries one week sooner than scheduled and expand its manufacturing capacity in Europe.
The EU is far behind Britain and the United States in getting its population of 450 million vaccinated against the virus. The slow rollout has been blamed on a range of national problems as well as slower authorization of the vaccines and an initial shortage of supply.